Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC
Clinical trial NCT06177015 · RECRUITING
Trial details
- NCT number
- NCT06177015
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-11
- Primary completion
- 2025-12-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.